Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis
Background. There is significant controversy relating to whether chronic thromboembolic pulmonary hypertension (CTEPH) can be treated with pulmonary arterial hypertension- (PAH-) targeted therapies and which therapy is the optimal choice for patients. A large number of randomized controlled trials (...
Saved in:
Main Authors: | Yusi Chen, Fang Li, Jun Luo, Jingyuan Chen, Peng Luo, Jiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2021/1626971 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Fraser Rubens, et al.
Published: (2000-01-01) -
Chronic Thromboembolic Pulmonary Hypertension: Treat the Patient Not the Haemodynamics
by: Ben Dunne, et al.
Published: (2012-01-01) -
Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
by: Bodil Ivarsson, et al.
Published: (2014-01-01) -
The possibilities of lung perfusion scintigraphy in the diagnosis of pulmonary embolism and chronic thromboembolic pulmonary hypertension
by: V.Yu. Kundin, et al.
Published: (2017-06-01) -
Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial
by: Keiichi Fukuda, et al.
Published: (2022-07-01)